Vision and Mission
To be the most valuable radiopharmaceutical company in China, and one of the world's leaders.
Bring new hope to patients by developing the most innovative radioactive diagnostic and therapeutic products.More
Research and Development
Committed to the development, production and commercialization of diagnostic and therapeutic drugs in the field of nuclear medicine.
We have built a series of R&D pipelines for radiopharmaceutical drugs, including recombinant proteins, imaging and radiotherapeutic drugs.
- Recombinant proteins
- Targeted Radionuclide Imaging
- Targeted Radionuclide Therapy
Targeted Radionuclide Imaging
For diagnostic applications radioisotopes with short half-lives are used. With highly sensitive molecular imaging technologies like PET or SPECT, pictures of organs and lesions at molecular and cellular levels.
- SNA006(CD8 T cell)